Perceptive Xontogeny Venture Fund II, LP
- SEC CIK
- 0001851820
No open-market purchases or sales filed in the past year.
Current role at each company
- LONA LeonaBio, Inc.Director, 10% Owneras of Dec 23, 2025
- CRGX CARGO Therapeutics, Inc.Other: Former 10% Owneras of Nov 14, 2023
- LABP Landos Biopharma, Inc.10% Owneras of Jan 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Perceptive Xontogeny Venture Fund II, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRGX CARGO Therapeutics, Inc.
Other: Former 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 (view filing)4:32 PM ET | Nov 14 | Same day | Edelman Joseph and 3 othersOther: Former 10% Owner | PPurchase | +666.7K | $15.00 | +$10.0M | New position333.3K after | 2 lots |
LABP Landos Biopharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2023 (view filing)6:45 PM ET | Jan 10 | 1 day | Edelman Joseph and 4 others10% Owner | PPurchase | +30.9M | $0.54 | +$16.7M | –3.64M after | Derivative2 lots |